{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:41:21Z","timestamp":1792644081760,"version":"4.5.0"},"reference-count":109,"publisher":"American Society of Hematology","issue":"23","license":[{"start":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T00:00:00Z","timestamp":1646870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,12,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Multiple myeloma (MM) remains an incurable plasma cell malignancy that develops in the bone marrow (BM). This BM is partially responsible for protecting the MM cells against current standard-of-care therapies and for accommodating MM-related symptoms such as bone resorption and immune suppression. Increasing evidence has implicated extracellular vesicles (EV), including exosomes in the different processes within the BM. Exosomes are &amp;lt;150-nm-sized vesicles secreted by different cell types including MM cells. These vesicles contain protein and RNA cargo that they deliver to the recipient cell. In this way, they have been implicated in MM-related processes including osteolysis, angiogenesis, immune suppression, and drug resistance. Targeting exosome secretion could therefore potentially block these different processes. In this review, we will summarize the current findings of exosome-related processes in the BM and describe not only the current treatment strategies to counter them but also how exosomes can be harnessed to deliver toxic payloads. Finally, an overview of the different clinical studies that\u00a0investigate EV cargo as potential MM biomarkers in liquid biopsies will be discussed.<\/jats:p>","DOI":"10.1182\/blood.2021014749","type":"journal-article","created":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T18:18:49Z","timestamp":1646936329000},"page":"2429-2442","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":50,"title":["Exosomes in multiple myeloma: from bench to\u00a0bedside"],"prefix":"10.1182","volume":"140","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0805-6581","authenticated-orcid":false,"given":"Eline","family":"Menu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2137-7179","authenticated-orcid":false,"given":"Karin","family":"Vanderkerken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"9","key":"2022120816274217200_bib1","doi-asserted-by":"crossref","first-page":"e1406","DOI":"10.1634\/theoncologist.2020-0141","article-title":"Multiple myeloma incidence and mortality around the globe: interrelations between health access and quality, economic resources, and patient empowerment","volume":"25","author":"Ludwig","year":"2020","journal-title":"Oncologist"},{"issue":"12","key":"2022120816274217200_bib2","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"issue":"10272","key":"2022120816274217200_bib3","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0140-6736(21)00135-5","article-title":"Multiple myeloma","volume":"397","author":"van de Donk","year":"2021","journal-title":"Lancet"},{"key":"2022120816274217200_bib4","doi-asserted-by":"crossref","first-page":"625199","DOI":"10.3389\/fonc.2020.625199","article-title":"Game of bones: how myeloma manipulates its microenvironment","volume":"10","author":"Moser-Katz","year":"2021","journal-title":"Front Oncol"},{"key":"2022120816274217200_bib5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/978-3-030-67171-6_5","article-title":"Exomeres: a new member of extracellular vesicles family","volume":"97","author":"Anand","year":"2021","journal-title":"Subcell Biochem"},{"issue":"6478","key":"2022120816274217200_bib6","doi-asserted-by":"crossref","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"issue":"1","key":"2022120816274217200_bib7","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1038\/ncomms4477","article-title":"Syntenin-ALIX exosome biogenesis and budding into multivesicular bodies are controlled by ARF6 and PLD2","volume":"5","author":"Ghossoub","year":"2014","journal-title":"Nat Commun"},{"key":"2022120816274217200_bib8","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ceb.2014.05.004","article-title":"Biogenesis and secretion of exosomes","volume":"29","author":"Kowal","year":"2014","journal-title":"Curr Opin Cell Biol"},{"issue":"7","key":"2022120816274217200_bib9","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/j.1600-0854.2009.00920.x","article-title":"Multivesicular endosome biogenesis in the absence of ESCRTs","volume":"10","author":"Stuffers","year":"2009","journal-title":"Traffic"},{"issue":"1-2","key":"2022120816274217200_bib10","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/21541248.2016.1264352","article-title":"New insights into the function of Rab GTPases in the context of exosomal secretion","volume":"9","author":"Blanc","year":"2018","journal-title":"Small GTPases"},{"issue":"8","key":"2022120816274217200_bib11","doi-asserted-by":"crossref","first-page":"R397","DOI":"10.1016\/j.cub.2018.01.005","article-title":"SNARE complex assembly and disassembly","volume":"28","author":"Yoon","year":"2018","journal-title":"Curr Biol"},{"issue":"1","key":"2022120816274217200_bib12","doi-asserted-by":"crossref","first-page":"163","DOI":"10.7150\/ijbs.53671","article-title":"Regulation of exosome production and cargo sorting","volume":"17","author":"Wei","year":"2021","journal-title":"Int J Biol Sci"},{"issue":"1","key":"2022120816274217200_bib13","first-page":"3","article-title":"Routes and mechanisms of extracellular vesicle uptake","volume":"3","author":"Mulcahy","year":"2014","journal-title":"J\u00a0Extracell Vesicles"},{"issue":"1","key":"2022120816274217200_bib14","doi-asserted-by":"crossref","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines","volume":"7","author":"Th\u00e9ry","year":"2018","journal-title":"J\u00a0Extracell Vesicles"},{"issue":"6","key":"2022120816274217200_bib15","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41556-021-00693-y","article-title":"Quantitative proteomics identifies the core proteome of exosomes with syntenin-1 as the highest abundant protein and a putative universal biomarker","volume":"23","author":"Kugeratski","year":"2021","journal-title":"Nat Cell Biol"},{"key":"2022120816274217200_bib16","doi-asserted-by":"crossref","first-page":"738","DOI":"10.3389\/fimmu.2018.00738","article-title":"Extracellular vesicle heterogeneity: subpopulations, isolation techniques, and diverse functions in cancer progression","volume":"9","author":"Willms","year":"2018","journal-title":"Front Immunol"},{"issue":"18","key":"2022120816274217200_bib17","doi-asserted-by":"crossref","first-page":"E6466","DOI":"10.3390\/ijms21186466","article-title":"A\u00a0review of exosomal isolation methods: is size exclusion chromatography the best option?","volume":"21","author":"Sidhom","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2022120816274217200_bib18","doi-asserted-by":"crossref","first-page":"23550","DOI":"10.1038\/srep23550","article-title":"Residual matrix from different separation techniques impacts exosome biological activity","volume":"6","author":"Paolini","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"2022120816274217200_bib19","doi-asserted-by":"crossref","first-page":"1379835","DOI":"10.1080\/20013078.2017.1379835","article-title":"Is your article EV-TRACKed?","volume":"6","author":"Van Deun","year":"2017","journal-title":"J\u00a0Extracell Vesicles"},{"issue":"7495","key":"2022120816274217200_bib20","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nature13034","article-title":"Direct measurement of local oxygen concentration in the bone marrow of live animals","volume":"508","author":"Spencer","year":"2014","journal-title":"Nature"},{"issue":"3","key":"2022120816274217200_bib21","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2141.1994.tb08304.x","article-title":"Bone marrow angiogenesis and progression in multiple myeloma","volume":"87","author":"Vacca","year":"1994","journal-title":"Br J Haematol"},{"issue":"25","key":"2022120816274217200_bib22","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1182\/blood-2014-05-576116","article-title":"Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1","volume":"124","author":"Umezu","year":"2014","journal-title":"Blood"},{"issue":"2","key":"2022120816274217200_bib23","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/path.4712","article-title":"Multiple myeloma exosomes establish a favourable bone marrow microenvironment with enhanced angiogenesis and immunosuppression","volume":"239","author":"Wang","year":"2016","journal-title":"J\u00a0Pathol"},{"issue":"26","key":"2022120816274217200_bib24","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1038\/s41388-019-0788-4","article-title":"piRNA-823 delivered by multiple myeloma-derived extracellular vesicles promoted tumorigenesis through re-educating endothelial cells in the tumor environment","volume":"38","author":"Li","year":"2019","journal-title":"Oncogene"},{"key":"2022120816274217200_bib25","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3389\/fimmu.2014.00517","article-title":"Immunoglobulin free light chains and GAGs mediate multiple myeloma extracellular vesicles uptake and secondary NF\u03baB nuclear translocation","volume":"5","author":"Di Noto","year":"2014","journal-title":"Front Immunol"},{"issue":"13","key":"2022120816274217200_bib26","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/bloodadvances.2016003251","article-title":"Replenishing exosomes from older bone marrow stromal cells with miR-340 inhibits myeloma-related angiogenesis","volume":"1","author":"Umezu","year":"2017","journal-title":"Blood Adv"},{"issue":"1","key":"2022120816274217200_bib27","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s12967-020-02468-9","article-title":"C6-ceramide treatment inhibits the proangiogenic activity of multiple myeloma exosomes via the miR-29b\/Akt pathway","volume":"18","author":"Liu","year":"2020","journal-title":"J\u00a0Transl Med"},{"issue":"6","key":"2022120816274217200_bib28","first-page":"2873","article-title":"Microvesicles shed from bortezomib-treated or lenalidomide-treated human myeloma cells inhibit angiogenesis in\u00a0vitro","volume":"39","author":"Guo","year":"2018","journal-title":"Oncol Rep"},{"issue":"1","key":"2022120816274217200_bib29","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10456-018-9649-y","article-title":"Extracellular vesicles of multiple myeloma cells utilize the proteasome inhibitor mechanism to moderate endothelial angiogenesis","volume":"22","author":"Zarfati","year":"2019","journal-title":"Angiogenesis"},{"issue":"5","key":"2022120816274217200_bib30","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S1470-2045(03)01076-3","article-title":"Aetiology of bone disease and the role of bisphosphonates in multiple myeloma","volume":"4","author":"Ashcroft","year":"2003","journal-title":"Lancet Oncol"},{"issue":"15","key":"2022120816274217200_bib31","doi-asserted-by":"crossref","first-page":"13772","DOI":"10.18632\/oncotarget.3830","article-title":"Involvement of multiple myeloma cell-derived exosomes in osteoclast differentiation","volume":"6","author":"Raimondi","year":"2015","journal-title":"Oncotarget"},{"issue":"8","key":"2022120816274217200_bib32","doi-asserted-by":"crossref","first-page":"E2167","DOI":"10.3390\/cancers12082167","article-title":"Multiple myeloma-derived extracellular vesicles induce osteoclastogenesis through the activation of the XBP1\/IRE1\u03b1 axis","volume":"12","author":"Raimondi","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"27","key":"2022120816274217200_bib33","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1182\/bloodadvances.2017010801","article-title":"Hypoxia promotes IL-32 expression in myeloma cells, and high expression is associated with poor survival and bone loss","volume":"1","author":"Zahoor","year":"2017","journal-title":"Blood Adv"},{"issue":"11","key":"2022120816274217200_bib34","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41408-018-0139-7","article-title":"Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblasts","volume":"8","author":"Faict","year":"2018","journal-title":"Blood Cancer J"},{"issue":"1","key":"2022120816274217200_bib35","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13045-018-0689-y","article-title":"Multiple myeloma-derived exosomes are enriched of amphiregulin (AREG) and activate the epidermal growth factor pathway in the bone microenvironment leading to osteoclastogenesis","volume":"12","author":"Raimondo","year":"2019","journal-title":"J\u00a0Hematol Oncol"},{"issue":"2","key":"2022120816274217200_bib36","doi-asserted-by":"crossref","first-page":"E449","DOI":"10.3390\/cancers12020449","article-title":"Extracellular vesicle microRNAs contribute to the osteogenic inhibition of mesenchymal stem cells in multiple myeloma","volume":"12","author":"Raimondo","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"1","key":"2022120816274217200_bib37","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1136\/jim-2019-001010","article-title":"Multiple myeloma-derived exosomes inhibit osteoblastic differentiation and improve IL-6 secretion of BMSCs from multiple myeloma","volume":"68","author":"Liu","year":"2020","journal-title":"J\u00a0Investig Med"},{"issue":"41","key":"2022120816274217200_bib38","doi-asserted-by":"crossref","first-page":"5508","DOI":"10.1038\/s41388-018-0359-0","article-title":"Exosome-mediated transfer of lncRUNX2-AS1 from multiple myeloma cells to MSCs contributes to osteogenesis","volume":"37","author":"Li","year":"2018","journal-title":"Oncogene"},{"issue":"1","key":"2022120816274217200_bib39","doi-asserted-by":"crossref","first-page":"196","DOI":"10.7150\/thno.27550","article-title":"Tumor-derived extracellular vesicles inhibit osteogenesis and exacerbate myeloma bone disease","volume":"9","author":"Zhang","year":"2019","journal-title":"Theranostics"},{"issue":"1","key":"2022120816274217200_bib40","doi-asserted-by":"crossref","first-page":"111490","DOI":"10.1016\/j.yexcr.2019.07.003","article-title":"Myeloma-derived extracellular vesicles mediate HGF\/c-Met signaling in osteoblast-like cells","volume":"383","author":"Str\u00f8mme","year":"2019","journal-title":"Exp Cell Res"},{"issue":"suppl 1","key":"2022120816274217200_bib41","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1517\/14712598.2013.799130","article-title":"Immunologic microenviron ment and personalized treatment in multiple myeloma","volume":"13","author":"Rossi","year":"2013","journal-title":"Expert Opin Biol Ther"},{"issue":"41","key":"2022120816274217200_bib42","doi-asserted-by":"crossref","first-page":"43992","DOI":"10.18632\/oncotarget.6083","article-title":"The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"issue":"8","key":"2022120816274217200_bib43","doi-asserted-by":"crossref","first-page":"e1458809","DOI":"10.1080\/2162402X.2018.1458809","article-title":"Microvesicles released from multiple myeloma cells are equipped with ectoenzymes belonging to canonical and non-canonical adenosinergic pathways and produce adenosine from ATP and NAD","volume":"7","author":"Morandi","year":"2018","journal-title":"OncoImmunology"},{"issue":"21","key":"2022120816274217200_bib44","doi-asserted-by":"crossref","first-page":"129348","DOI":"10.1172\/jci.insight.129348","article-title":"MiR-16 regulates crosstalk in NF-\u03baB tolerogenic inflammatory signaling between myeloma cells and bone marrow macrophages","volume":"4","author":"Khalife","year":"2019","journal-title":"JCI Insight"},{"issue":"10","key":"2022120816274217200_bib45","first-page":"2825","article-title":"Exosomal miR-1305 in the oncogenic activity of hypoxic multiple myeloma cells: a biomarker for predicting prognosis","volume":"12","author":"Lee","year":"2021","journal-title":"J\u00a0Cancer"},{"key":"2022120816274217200_bib46","doi-asserted-by":"crossref","first-page":"106566","DOI":"10.1016\/j.leukres.2021.106566","article-title":"Exosome-derived miR-let-7c promotes angiogenesis in multiple myeloma by polarizing M2 macrophages in the bone marrow microenvironment","volume":"105","author":"Tian","year":"2021","journal-title":"Leuk Res"},{"issue":"7","key":"2022120816274217200_bib47","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1158\/2326-6066.CIR-17-0604","article-title":"Drug-induced senescent multiple myeloma cells elicit NK cell proliferation by direct or exosome-mediated IL15 Trans-presentation","volume":"6","author":"Borrelli","year":"2018","journal-title":"Cancer Immunol Res"},{"issue":"3","key":"2022120816274217200_bib48","doi-asserted-by":"crossref","first-page":"e1279372","DOI":"10.1080\/2162402X.2017.1279372","article-title":"Genotoxic stress modulates the release of exosomes from multiple myeloma cells capable of activating NK cell cytokine production: Role of HSP70\/TLR2\/NF-kB axis","volume":"6","author":"Vulpis","year":"2017","journal-title":"OncoImmunology"},{"issue":"2","key":"2022120816274217200_bib49","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s40199-020-00372-7","article-title":"Long-chain polyunsaturated omega-3 fatty acids reduce multiple myeloma exosome-mediated suppression of NK cell cytotoxicity","volume":"28","author":"Moloudizargari","year":"2020","journal-title":"Daru"},{"issue":"4","key":"2022120816274217200_bib50","first-page":"31","article-title":"Involvement of MM cell-derived exosomes in T lymphocytes immune responses","volume":"20","author":"Shao","year":"2020","journal-title":"Oncol Lett"},{"issue":"4","key":"2022120816274217200_bib51","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1172\/JCI66517","article-title":"BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression","volume":"123","author":"Roccaro","year":"2013","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"2022120816274217200_bib52","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood-2014-03-562439","article-title":"Bone marrow stromal cell-derived exosomes as communicators in drug resistance in multiple myeloma cells","volume":"124","author":"Wang","year":"2014","journal-title":"Blood"},{"issue":"23","key":"2022120816274217200_bib53","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1182\/blood-2016-05-715961","article-title":"Caspase-3-dependent cleavage of Bcl-xL in the stroma exosomes is required for their uptake by hematological malignant cells","volume":"128","author":"Vardaki","year":"2016","journal-title":"Blood"},{"issue":"21","key":"2022120816274217200_bib54","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1182\/bloodadvances.2019000403","article-title":"Induction of multiple myeloma bone marrow stromal cell apoptosis by inhibiting extracellular vesicle miR-10a secretion","volume":"3","author":"Umezu","year":"2019","journal-title":"Blood Adv"},{"issue":"4","key":"2022120816274217200_bib55","doi-asserted-by":"crossref","first-page":"e23447","DOI":"10.1097\/MD.0000000000023447","article-title":"Bone marrow stromal cells derived exosomal miR-10a and miR-16 may be involved in progression of patients with multiple myeloma by regulating EPHA8 or IGF1R\/CCND1","volume":"100","author":"Peng","year":"2021","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"2022120816274217200_bib56","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/path.5852","article-title":"Myeloma cells regulate miRNA transfer from fibroblast-derived exosomes by expression of lncRNAs","volume":"256","author":"Saltarella","year":"2021","journal-title":"J\u00a0Pathol"},{"issue":"1","key":"2022120816274217200_bib57","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jcyt.2018.10.006","article-title":"Exosome-transmitted LINC00461 promotes multiple myeloma cell proliferation and suppresses apoptosis by modulating microRNA\/BCL-2 expression","volume":"21","author":"Deng","year":"2019","journal-title":"Cytotherapy"},{"issue":"1","key":"2022120816274217200_bib58","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1186\/s12935-020-01475-6","article-title":"Circ_0007841 promotes the progression of multiple myeloma through targeting miR-338-3p\/BRD4 signaling cascade","volume":"20","author":"Wang","year":"2020","journal-title":"Cancer Cell Int"},{"issue":"1","key":"2022120816274217200_bib59","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/s41375-019-0493-x","article-title":"Targeting histone deacetylase 3 (HDAC3) in the bone marrow microenvironment inhibits multiple myeloma proliferation by modulating exosomes and IL-6 trans-signaling","volume":"34","author":"Ho","year":"2020","journal-title":"Leukemia"},{"issue":"6","key":"2022120816274217200_bib60","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1158\/1078-0432.CCR-18-2363","article-title":"Exosome-transmitted PSMA3 and PSMA3-AS1 promote proteasome inhibitor resistance in multiple myeloma","volume":"25","author":"Xu","year":"2019","journal-title":"Clin Cancer Res"},{"key":"2022120816274217200_bib61","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.3389\/fimmu.2020.01816","article-title":"Intravenous immunoglobulin G suppresses heat shock protein (HSP)-70 expression and enhances the activity of HSP90 and proteasome inhibitors","volume":"11","author":"Jones","year":"2020","journal-title":"Front Immunol"},{"key":"2022120816274217200_bib62","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.matbio.2017.09.001","article-title":"Chemotherapy induces secretion of exosomes loaded with heparanase that degrades extracellular matrix and impacts tumor and host cell behavior","volume":"65","author":"Bandari","year":"2018","journal-title":"Matrix Biol"},{"issue":"12","key":"2022120816274217200_bib63","doi-asserted-by":"crossref","first-page":"E1823","DOI":"10.3390\/cancers11121823","article-title":"The transfer of sphingomyelinase contributes to drug resistance in multiple myeloma","volume":"11","author":"Faict","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"4","key":"2022120816274217200_bib64","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/leu.2013.254","article-title":"Bone marrow fibroblasts parallel multiple myeloma progression in patients and mice: in\u00a0vitro and in\u00a0vivo studies","volume":"28","author":"Frassanito","year":"2014","journal-title":"Leukemia"},{"issue":"1","key":"2022120816274217200_bib65","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.canlet.2016.04.024","article-title":"Induction of miR-146a by multiple myeloma cells in mesenchymal stromal cells stimulates their pro-tumoral activity","volume":"377","author":"De Veirman","year":"2016","journal-title":"Cancer Lett"},{"key":"2022120816274217200_bib66","doi-asserted-by":"crossref","first-page":"9012152","DOI":"10.1155\/2017\/9012152","article-title":"Multiple myeloma-derived exosomes regulate the functions of mesenchymal stem cells partially via modulating miR-21 and miR-146a","volume":"2017","author":"Cheng","year":"2017","journal-title":"Stem Cells Int"},{"issue":"2","key":"2022120816274217200_bib67","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/path.5187","article-title":"Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes","volume":"247","author":"Frassanito","year":"2019","journal-title":"J\u00a0Pathol"},{"issue":"13-14","key":"2022120816274217200_bib68","doi-asserted-by":"crossref","first-page":"e2000119","DOI":"10.1002\/pmic.202000119","article-title":"Human myeloma cell- and plasma-derived extracellular vesicles contribute to functional regulation of stromal cells","volume":"21","author":"Reale","year":"2021","journal-title":"Proteomics"},{"issue":"4","key":"2022120816274217200_bib69","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/aps.2017.118","article-title":"The ceramide pathway is involved in the survival, apoptosis and exosome functions of human multiple myeloma cells in\u00a0vitro","volume":"39","author":"Cheng","year":"2018","journal-title":"Acta Pharmacol Sin"},{"key":"2022120816274217200_bib70","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/978-3-030-34521-1_12","article-title":"Heparanase: a dynamic promoter of myeloma progression","volume":"1221","author":"Purushothaman","year":"2020","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"2022120816274217200_bib71","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/cr.2015.29","article-title":"Heparanase activates the syndecan-syntenin-ALIX exosome pathway","volume":"25","author":"Roucourt","year":"2015","journal-title":"Cell Res"},{"issue":"14","key":"2022120816274217200_bib72","doi-asserted-by":"crossref","first-page":"10093","DOI":"10.1074\/jbc.C112.444562","article-title":"Heparanase regulates secretion, composition, and function of tumor cell-derived exosomes","volume":"288","author":"Thompson","year":"2013","journal-title":"J\u00a0Biol Chem"},{"issue":"4","key":"2022120816274217200_bib73","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1074\/jbc.M115.686295","article-title":"Fibronectin on the surface of myeloma cell-derived exosomes mediates exosome-cell interactions","volume":"291","author":"Purushothaman","year":"2016","journal-title":"J\u00a0Biol Chem"},{"issue":"2","key":"2022120816274217200_bib74","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.18632\/oncotarget.6408","article-title":"Targeting heparanase overcomes chemoresistance and diminishes relapse in myeloma","volume":"7","author":"Ramani","year":"2016","journal-title":"Oncotarget"},{"issue":"10","key":"2022120816274217200_bib75","doi-asserted-by":"crossref","first-page":"e469","DOI":"10.3324\/haematol.2017.182865","article-title":"Phase I study of the heparanase inhibitor roneparstat: an innovative approach for ultiple myeloma therapy","volume":"103","author":"Galli","year":"2018","journal-title":"Haematologica"},{"key":"2022120816274217200_bib76","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2147\/OTT.S286751","article-title":"MicroRNA-1252-5p associated with extracellular vesicles enhances bortezomib sensitivity in multiple myeloma cells by targeting heparanase","volume":"14","author":"Rodrigues-Junior","year":"2021","journal-title":"OncoTargets Ther"},{"issue":"5","key":"2022120816274217200_bib77","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.7150\/thno.47996","article-title":"Endocytic pathway inhibition attenuates extracellular\u00a0vesicle-induced reduction of chemosensitivity to bortezomib in multiple myeloma cells","volume":"11","author":"Tu","year":"2021","journal-title":"Theranostics"},{"issue":"11","key":"2022120816274217200_bib78","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1111\/j.1582-4934.2009.00851.x","article-title":"Membrane-bound HSP70-engineered myeloma cell-derived exosomes stimulate more efficient CD8(+) CTL- and NK-mediated antitumour immunity than exosomes released from heat-shocked tumour cells expressing cytoplasmic HSP70","volume":"14","author":"Xie","year":"2010","journal-title":"J\u00a0Cell Mol Med"},{"issue":"9","key":"2022120816274217200_bib79","doi-asserted-by":"crossref","first-page":"14360","DOI":"10.1021\/acsnano.1c03517","article-title":"Apoptotic extracellular vesicles ameliorate multiple myeloma by restoring Fas-mediated apoptosis","volume":"15","author":"Wang","year":"2021","journal-title":"ACS Nano"},{"issue":"14","key":"2022120816274217200_bib80","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1158\/1078-0432.CCR-15-2170","article-title":"TNF- (TRAIL)-armed exosomes deliver proapoptotic signals to tumor site","volume":"22","author":"Rivoltini","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"7659","key":"2022120816274217200_bib81","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature22341","article-title":"Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer","volume":"546","author":"Kamerkar","year":"2017","journal-title":"Nature"},{"issue":"8","key":"2022120816274217200_bib82","doi-asserted-by":"crossref","first-page":"99263","DOI":"10.1172\/jci.insight.99263","article-title":"Generation and testing of clinical-grade exosomes for pancreatic cancer","volume":"3","author":"Mendt","year":"2018","journal-title":"JCI Insight"},{"issue":"3","key":"2022120816274217200_bib83","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/s41375-020-01104-1","article-title":"Clinical relevance of extracellular vesicles in hematological neoplasms: from liquid biopsy to cell biopsy","volume":"35","author":"Trino","year":"2021","journal-title":"Leukemia"},{"issue":"8","key":"2022120816274217200_bib84","doi-asserted-by":"crossref","first-page":"e70811","DOI":"10.1371\/journal.pone.0070811","article-title":"C-src enriched serum microvesicles are generated in malignant plasma cell dyscrasia","volume":"8","author":"Di Noto","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"2022120816274217200_bib85","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12943-017-0730-8","article-title":"Monitoring multiple myeloma by idiotype-specific peptide binders of tumor-derived exosomes","volume":"16","author":"Iaccino","year":"2017","journal-title":"Mol Cancer"},{"issue":"1","key":"2022120816274217200_bib86","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.neo.2015.11.011","article-title":"Isolation of human CD138(+) microparticles from the plasma of patients with multiple myeloma","volume":"18","author":"Krishnan","year":"2016","journal-title":"Neoplasia"},{"issue":"4","key":"2022120816274217200_bib87","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/hon.2648","article-title":"The potential diagnostic power of CD138+ microparticles from the plasma analysis for multiple myeloma clinical monitoring","volume":"37","author":"Liu","year":"2019","journal-title":"Hematol Oncol"},{"issue":"3","key":"2022120816274217200_bib88","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41408-020-0304-7","article-title":"A\u00a0liquid biopsy to detect multidrug resistance and disease burden in multiple myeloma","volume":"10","author":"Rajeev Krishnan","year":"2020","journal-title":"Blood Cancer J"},{"issue":"12","key":"2022120816274217200_bib89","doi-asserted-by":"crossref","first-page":"9739","DOI":"10.1007\/s13277-015-3741-3","article-title":"High serum levels of extracellular vesicles expressing malignancy-related markers are released in patients with various types of hematological neoplastic disorders","volume":"36","author":"Caivano","year":"2015","journal-title":"Tumour Biol"},{"key":"2022120816274217200_bib90","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.2147\/IJN.S303391","article-title":"Analysis of amount, size, protein phenotype and molecular content of circulating extracellular vesicles identifies new biomarkers in multiple myeloma","volume":"16","author":"Laurenzana","year":"2021","journal-title":"Int J Nanomedicine"},{"key":"2022120816274217200_bib91","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jprot.2015.12.016","article-title":"Proteomic characterization of circulating extracellular vesicles identifies novel serum myeloma associated markers","volume":"136","author":"Harshman","year":"2016","journal-title":"J\u00a0Proteomics"},{"issue":"20","key":"2022120816274217200_bib92","first-page":"3013","article-title":"Characterization of multiple myeloma vesicles by label-free relative quantitation","volume":"13","author":"Harshman","year":"2013","journal-title":"Proteomics"},{"issue":"5","key":"2022120816274217200_bib93","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/ejh.13371","article-title":"Circulating extracellular vesicle-associated CD163 and CD206 in multiple myeloma","volume":"104","author":"Kvorning","year":"2020","journal-title":"Eur J Haematol"},{"key":"2022120816274217200_bib94","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.bios.2015.09.061","article-title":"Merging colloidal nanoplasmonics and surface plasmon resonance spectroscopy for enhanced profiling of multiple myeloma-derived exosomes","volume":"77","author":"Di Noto","year":"2016","journal-title":"Biosens Bioelectron"},{"issue":"47","key":"2022120816274217200_bib95","doi-asserted-by":"crossref","first-page":"30436","DOI":"10.1021\/acsomega.0c03813","article-title":"Raman spectroscopic stratification of multiple myeloma patients based on exosome profiling","volume":"5","author":"Russo","year":"2020","journal-title":"ACS Omega"},{"issue":"17","key":"2022120816274217200_bib96","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1182\/blood-2016-09-742296","article-title":"Prognostic role of circulating exosomal miRNAs in multiple myeloma","volume":"129","author":"Manier","year":"2017","journal-title":"Blood"},{"issue":"1","key":"2022120816274217200_bib97","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s13402-016-0300-x","article-title":"MicroRNA-155 in serum-derived extracellular vesicles as a potential biomarker for hematologic malignancies: a short report","volume":"40","author":"Caivano","year":"2017","journal-title":"Cell Oncol (Dordr)"},{"issue":"4","key":"2022120816274217200_bib98","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/hon.2639","article-title":"Serum exosomal microRNAs as novel biomarkers for multiple myeloma","volume":"37","author":"Zhang","year":"2019","journal-title":"Hematol Oncol"},{"key":"2022120816274217200_bib99","doi-asserted-by":"crossref","first-page":"1575468","DOI":"10.1155\/2019\/1575468","article-title":"Potential relationship between clinical significance and serum exosomal miRNAs in patients with multiple myeloma","volume":"2019","author":"Zhang","year":"2019","journal-title":"BioMed Res Int"},{"issue":"5","key":"2022120816274217200_bib100","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/hon.2554","article-title":"Circulating exosomal long noncoding RNA PRINS-First findings in monoclonal gammopathies","volume":"36","author":"Sedlarikova","year":"2018","journal-title":"Hematol Oncol"},{"issue":"21","key":"2022120816274217200_bib101","doi-asserted-by":"crossref","first-page":"30876","DOI":"10.18632\/oncotarget.9021","article-title":"Potential role of exosome-associated microRNA panels and in\u00a0vivo environment to predict drug resistance for patients with multiple myeloma","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"issue":"5","key":"2022120816274217200_bib102","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/cbin.11540","article-title":"Exosomal mRNAs and lncRNAs involved in multiple myeloma resistance to bortezomib","volume":"45","author":"Tang","year":"2021","journal-title":"Cell Biol Int"},{"issue":"4","key":"2022120816274217200_bib103","doi-asserted-by":"crossref","first-page":"248","DOI":"10.4274\/tjh.galenos.2020.2020.0243","article-title":"Circulating exosomal CircMYC is associated with recurrence and bortezomib resistance in patients with multiple myeloma","volume":"37","author":"Luo","year":"2020","journal-title":"Turk J Haematol"},{"key":"2022120816274217200_bib104","doi-asserted-by":"crossref","first-page":"109872","DOI":"10.1016\/j.cellsig.2020.109872","article-title":"Exosomal circRNA as a novel potential therapeutic target for multiple myeloma-related peripheral neuropathy","volume":"78","author":"Zhang","year":"2021","journal-title":"Cell Signal"},{"issue":"1","key":"2022120816274217200_bib105","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1186\/s12935-021-02011-w","article-title":"Exosomal circRNA as a novel potential therapeutic target for multiple myeloma-related myocardial damage","volume":"21","author":"Sun","year":"2021","journal-title":"Cancer Cell Int"},{"key":"2022120816274217200_bib106","article-title":"A\u00a0novel circRNA-miRNA-mRNA network revealed exosomal circ-ATP10A as a biomarker for multiple myeloma angiogenesis","author":"Yu","year":"2021","journal-title":"Bioengineered"},{"issue":"15","key":"2022120816274217200_bib107","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.3390\/cancers13153827","article-title":"Characteristics and clinical\u00a0application of extracellular vesicle-derived DNA","volume":"13","author":"Hur","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2022120816274217200_bib108","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.addr.2020.03.002","article-title":"An emerging focus on lipids in extracellular vesicles","volume":"159","author":"Skotland","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"issue":"9","key":"2022120816274217200_bib109","first-page":"1913","article-title":"Tumor microenvironment interruption: a novel anti-cancer mechanism of Proton-pump inhibitor in gastric cancer by suppressing the\u00a0release of microRNA-carrying exosomes","volume":"7","author":"Guan","year":"2017","journal-title":"Am J Cancer Res"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/140\/23\/2429\/2019794\/blood_bld-2021-014749-c-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/140\/23\/2429\/2019794\/blood_bld-2021-014749-c-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T16:28:34Z","timestamp":1670516914000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/140\/23\/2429\/484361\/Exosomes-in-multiple-myeloma-from-bench-to-bedside"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,8]]},"references-count":109,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2022,12,8]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2021014749","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,8]]}}}